Vestor Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.92M | Buy |
10,787
+7,302
| +210% | +$7.4M | 0.72% | 43 |
|
|
2025
Q4 | $25.1M | Buy |
3,485
+2,421
| +228% | +$2.31M | 1.73% | 16 |
|
|
2025
Q3 | $811K | Sell |
1,064
-3,062
| -74% | -$2.28M | 0.05% | 96 |
|
|
2025
Q2 | $1.69M | Sell |
4,126
-18,926
| -82% | -$14.7M | 0.13% | 80 |
|
|
2025
Q1 | $19M | Sell |
23,052
-2,253
| -9% | -$1.87M | 1.57% | 20 |
|
|
2024
Q4 | $19.5M | Sell |
25,305
-20,515
| -45% | -$17M | 1.49% | 14 |
|
|
2024
Q3 | $40.6M | Sell |
45,820
-11,980
| -21% | -$10.8M | 3.19% | 9 |
|
|
2024
Q2 | $52.3M | Buy |
57,800
+17,503
| +43% | +$14M | 4.22% | 8 |
|
|
2024
Q1 | $31.4M | Buy |
40,297
+4,365
| +12% | +$3.11M | 2.65% | 9 |
|
|
2023
Q4 | $20.9M | Buy |
35,932
+933
| +3% | +$545K | 2% | 13 |
|
|
2023
Q3 | $18.8M | Sell |
34,999
-305
| -0.9% | -$157K | 2.04% | 14 |
|
|
2023
Q2 | $16.6M | Buy |
35,304
+12,682
| +56% | +$5.32M | 1.75% | 17 |
|
|
2023
Q1 | $7.77M | Sell |
22,622
-33,336
| -60% | -$11.2M | 0.91% | 41 |
|
|
2022
Q4 | $20.5M | Buy |
55,958
+13,689
| +32% | +$4.85M | 2.47% | 10 |
|
|
2022
Q3 | $13.7M | Sell |
42,269
-23,448
| -36% | -$7.43M | 1.79% | 18 |
|
|
2022
Q2 | $21.3M | Sell |
65,717
-317
| -0.5% | -$95.2K | 2.58% | 10 |
|
|
2022
Q1 | $18.9M | Buy |
66,034
+11,283
| +21% | +$2.9M | 1.88% | 16 |
|
|
2021
Q4 | $15.1M | Buy |
54,751
+159
| +0.3% | +$40.3K | 1.44% | 22 |
|
|
2021
Q3 | $12.6M | Sell |
54,592
-114
| -0.2% | -$28.1K | 1.32% | 27 |
|
|
2021
Q2 | $12.6M | Sell |
54,706
-2,606
| -5% | -$523K | 1.32% | 30 |
|
|
2021
Q1 | $10.7M | Buy |
57,312
+579
| +1% | +$113K | 1.22% | 31 |
|
|
2020
Q4 | $9.58M | Buy |
56,733
+24
| +0% | +$3.58K | 1.16% | 31 |
|
|
2020
Q3 | $8.39M | Buy |
+56,709
| New | +$8.78M | 1.19% | 32 |
|
|
2020
Q1 | $6.56M | Buy |
47,269
+46,558
| +6,548% | +$6.4M | 1.28% | 28 |
|
|
2019
Q4 | $93K | Sell |
711
-224
| -24% | -$26K | 0.01% | 121 |
|
|
2019
Q3 | $105K | Buy |
+935
| New | +$104K | 0.02% | 97 |
|
|
2016
Q4 | – | Sell |
-535
| Closed | -$43K | – | 102 |
|
|
2016
Q3 | $43K | Hold |
535
| – | – | 0.01% | 99 |
|
|
2016
Q2 | $42K | Buy |
+535
| New | +$40.3K | 0.01% | 90 |
|
|
2016
Q1 | – | Sell |
-535
| Closed | -$45K | – | 99 |
|
|
2015
Q4 | $45K | Hold |
535
| – | – | 0.01% | 97 |
|
|
2015
Q3 | $45K | Buy |
+535
| New | +$45.2K | 0.01% | 106 |
|
Other funds holding LLY
VCM
VPM
Vestor Capital's LLY Position: Q1 2026 in Review
Vestor Capital increased its Eli Lilly (LLY) stake by 210% in Q1 2026, buying an estimated $7.4M and bringing the position to 10,787 shares worth $9.92M. The position accounts for 0.72% of the portfolio, ranked #43.
Vestor Capital first reported a position in LLY in Q3 2015 and has held it in 30 quarters since. The position peaked at $52.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Vestor Capital held 10,787 shares of Eli Lilly worth $9.92M as of Q1 2026.
- Vestor Capital bought 7,302 Eli Lilly shares in Q1 2026, an estimated $7.4M.
- Eli Lilly made up 0.72% of Vestor Capital's portfolio in Q1 2026, its #43 holding.
- Vestor Capital first reported a position in Eli Lilly in Q3 2015 and has held it in 30 quarters since.
- Vestor Capital's Eli Lilly position peaked at $52.3M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.